Clinical Trial

Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This is a non-interventional study that will not pose any burden for the participants. The study subjects will be examined and treated in a standard manner according to current clinical recommendations for the treatment of overactive bladder (OAB). A portion of urine samples, which are routinely collected for biochemical and culture examinations as part of the diagnostic process, will be sent for examination of the characteristics of the urinary microbiome and metabolome (UMM) before and after treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-03.
Status change: Not Yet Recruiting → Recruiting 2025-05-01
Trial Details
NCT Number NCT06921746
Lead Sponsor University Hospital Ostrava
Collaborators: University Hospital Bulovka, Thomayer University Hospital, Institute of Microbiology of the Czech Academy of Sciences
Conditions Overactive Bladder
Enrollment 80 participants
Start Date 2025-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-04